Glivec and Tarceva Patent Cases Failed Because Evidence Of Efficacy Overlooked – IP Attorney
This article was originally published in PharmAsia News
Executive Summary
Despite industry criticism of India's patent enforcement system, recent IP cases, such as the Tarceva and Glivec cases, have demonstrated India's High Courts' ability to enforce judgments and reach well-reasoned conclusions with relative speed, according to Schiff Hardin attorney Christopher Ohly